Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference

Rhea-AI Summary

Aura Biosciences (NASDAQ: AURA) will participate in the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025. CEO Elisabet de los Pinos, PhD, will appear in a fireside chat at 10:50 a.m. ET. A live webcast will be available on the company’s Investors & Media Events & Presentations page and a replay will be archived for 90 days following the presentation.

This presentation provides an investor update opportunity with company leadership and a public webcast for remote access.

News Market Reaction

+1.10% 1.6x vol

16 alerts

+1.10% News Effect

+7.1% Peak in 5 hr 54 min

+$4M Valuation Impact

$392M Market Cap

1.6x Rel. Volume

On the day this news was published, AURA gained 1.10%, reflecting a mild positive market reaction. Argus tracked a peak move of +7.1% during that session. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $4M to the company's valuation, bringing the market cap to $392M at that time. Trading volume was above average at 1.6x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Tuesday, December 2, 2025, at 10:50 a.m. ET.

The live webcast of the fireside chat will be available on the “Investors & Media” page under the “Events & Presentations” section of the Company’s website at https://ir.aurabiosciences.com/events-and-presentations, where a replay of the webcast will be archived for 90 days following the presentation date.

About Aura Biosciences

Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for early choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Our mission is to grow as an innovative global oncology company that positively transforms the lives of patients.

For more information, visit aurabiosciences.com. Follow us on X (formerly Twitter) @AuraBiosciences and visit us on LinkedIn.

Investor and Media Relations Contact:
Alex Dasalla
Head of Investor Relations and Corporate Communications
IR@aurabiosciences.com

FAQ

When will Aura Biosciences (AURA) present at the Evercore Healthcare Conference?

Aura will present on Tuesday, December 2, 2025 at 10:50 a.m. ET.

Who from Aura Biosciences (AURA) will speak at the Evercore Healthcare Conference?

Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the fireside chat.

How can investors watch Aura Biosciences (AURA) at the Evercore Healthcare Conference?

A live webcast will be available on the company’s Investors & Media > Events & Presentations page.

Will there be a replay of the Aura Biosciences (AURA) webcast and for how long?

Yes. A replay will be archived on the events page for 90 days after the presentation.

Where is the Aura Biosciences (AURA) webcast hosted?

The webcast is hosted on the company’s investor website under Events & Presentations.

Is the Aura Biosciences (AURA) Evercore presentation available to the public?

Yes. The fireside chat will be webcast live and accessible via the investor website.